» Articles » PMID: 26366129

Barriers to Implementation of Rapid and Point-of-Care Tests for Human Immunodeficiency Virus Infection: Findings From a Systematic Review (1996-2014)

Overview
Journal Point Care
Date 2015 Sep 15
PMID 26366129
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: Five databases were searched, 16,672 citations were retrieved, and data were abstracted on 132 studies by 2 reviewers.

Findings: Across 3 levels (ie, patients, providers, and health systems), a majority (59%, 112/190) of the 190 barriers were related to the integration of RDT/POCT, followed by test-device-related concern (ie, accuracy) at 41% (78/190). At the patient level, a lack of awareness about tests (15/54, 28%) and time taken to test (12/54, 22%) dominated. At the provider and health system levels, integration of RDT/POCT in clinical workflows (7/24, 29%) and within hospitals (21/34, 62%) prevailed. Accuracy (57/78, 73%) was dominant only at the device level.

Interpretation: Integration barriers dominated the findings followed by test accuracy. Although accuracy has improved during the years, an ideal implementation could be achieved by improving the integration of RDT/POCT within clinics, hospitals, and health systems, with clear protocols, training on quality assurance and control, clear communication, and linkage plans to improve health outcomes of patients. This finding is pertinent for a future envisioned implementation and global scale-up of RDT/POCT-based initiatives.

Citing Articles

Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study).

OShea J, Hughes C, Molloy G, Cadogan C, Vellinga A, Fahey T HRB Open Res. 2025; 7:73.

PMID: 40060198 PMC: 11890267. DOI: 10.12688/hrbopenres.13962.2.


Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.

Rachlin A, Hampton L, Rota P, Mulders M, Papania M, Goodson J Vaccines (Basel). 2024; 12(8).

PMID: 39203949 PMC: 11360261. DOI: 10.3390/vaccines12080823.


Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling.

Wang Y, Kingwara L, Wagner A, Yongo N, Hassan S, Liu S BMJ Open. 2024; 14(4):e079988.

PMID: 38569688 PMC: 11146353. DOI: 10.1136/bmjopen-2023-079988.


Using queueing models as a decision support tool in allocating point-of-care HIV viral load testing machines in Kisumu County, Kenya.

Wang Y, Wagner A, Liu S, Kingwara L, Oyaro P, Brown E Health Policy Plan. 2023; 39(1):44-55.

PMID: 37949109 PMC: 10775219. DOI: 10.1093/heapol/czad111.


Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: a systematic review.

Zhang Y, Guy R, Camara H, Applegate T, Wiseman V, Treloar C BMJ Glob Health. 2022; 7(11).

PMID: 36319030 PMC: 9628546. DOI: 10.1136/bmjgh-2022-009408.


References
1.
Pai N, Joshi R, Dogra S, Taksande B, Kalantri S, Pai M . Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One. 2007; 2(4):e367. PMC: 1838923. DOI: 10.1371/journal.pone.0000367. View

2.
Cohall A, Dini S, Nye A, Dye B, Neu N, Hyden C . HIV testing preferences among young men of color who have sex with men. Am J Public Health. 2010; 100(10):1961-6. PMC: 2936982. DOI: 10.2105/AJPH.2008.140632. View

3.
Schito M, DSouza M, Owen S, Busch M . Challenges for rapid molecular HIV diagnostics. J Infect Dis. 2010; 201 Suppl 1:S1-6. PMC: 2841042. DOI: 10.1086/650394. View

4.
Hutchinson A, Corbie-Smith G, Thomas S, Mohanan S, Del Rio C . Understanding the patient's perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Educ Prev. 2004; 16(2):101-14. DOI: 10.1521/aeap.16.2.101.29394. View

5.
Malonza I, Richardson B, Kreiss J, Bwayo J, Stewart G . The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial. AIDS. 2002; 17(1):113-8. PMC: 3380077. DOI: 10.1097/00002030-200301030-00015. View